CN106310362A - Traditional Chinese medicine liquid dressing and preparation method - Google Patents
Traditional Chinese medicine liquid dressing and preparation method Download PDFInfo
- Publication number
- CN106310362A CN106310362A CN201610949158.2A CN201610949158A CN106310362A CN 106310362 A CN106310362 A CN 106310362A CN 201610949158 A CN201610949158 A CN 201610949158A CN 106310362 A CN106310362 A CN 106310362A
- Authority
- CN
- China
- Prior art keywords
- dressing
- chinese medicine
- extract
- traditional chinese
- liquid dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000007788 liquid Substances 0.000 title abstract description 65
- 239000003814 drug Substances 0.000 title abstract description 60
- 239000000284 extract Substances 0.000 claims abstract description 47
- 238000003756 stirring Methods 0.000 claims abstract description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 21
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 12
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229940041616 menthol Drugs 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 75
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 12
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 claims description 10
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000006136 alcoholysis reaction Methods 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims 2
- 239000011347 resin Substances 0.000 claims 2
- 241000403513 Schizostachyum chinense Species 0.000 claims 1
- 125000003172 aldehyde group Chemical group 0.000 claims 1
- 239000012467 final product Substances 0.000 claims 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract description 22
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 22
- 230000029663 wound healing Effects 0.000 abstract description 19
- 235000011187 glycerol Nutrition 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 9
- 206010059866 Drug resistance Diseases 0.000 abstract description 7
- 238000011049 filling Methods 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 3
- 241000218202 Coptis Species 0.000 abstract description 2
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 79
- 208000027418 Wounds and injury Diseases 0.000 description 26
- 206010052428 Wound Diseases 0.000 description 24
- 241000700159 Rattus Species 0.000 description 21
- 241000037740 Coptis chinensis Species 0.000 description 11
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical group O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 10
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 7
- 239000002861 polymer material Substances 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 229960003276 erythromycin Drugs 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000009513 Coptidis rhizoma extract Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 206010053615 Thermal burn Diseases 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000002951 depilatory effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241001360526 Escherichia coli ATCC 25922 Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 206010048038 Wound infection Diseases 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229910052979 sodium sulfide Inorganic materials 0.000 description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical group CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- XDVZNDLANFJOQR-UHFFFAOYSA-N Coptisine Natural products O=Cc1c2OCOc2ccc1C=C3/NCCc4cc5OCOc5cc34 XDVZNDLANFJOQR-UHFFFAOYSA-N 0.000 description 1
- 241000943303 Enterococcus faecalis ATCC 29212 Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 201000008225 Klebsiella pneumonia Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 1
- 206010035717 Pneumonia klebsiella Diseases 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000002318 adhesion promoter Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 238000001266 bandaging Methods 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- XYHOBCMEDLZUMP-UHFFFAOYSA-N coptisine Chemical compound C1=C2C=C(C3=C(C=C4OCOC4=C3)CC3)[N+]3=CC2=C2OCOC2=C1 XYHOBCMEDLZUMP-UHFFFAOYSA-N 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- FPJQGFLUORYYPE-UHFFFAOYSA-N epiberberine Chemical compound C1=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C2OCOC2=C1 FPJQGFLUORYYPE-UHFFFAOYSA-N 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010758 granulomatous inflammation Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/426—Immunomodulating agents, i.e. cytokines, interleukins, interferons
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于医用敷料领域,具体涉及一种中药液体敷料及制备方法,其含有如下重量百分比的组分:成膜材料1.0%‑6.0%,甘油2.0%‑4.0%,薄荷醇0.5%‑3.0%,黄连提取物0.3%‑1.0%,金银花提取物1.0%‑2.0%,其余为溶剂。本发明的中药液体敷料可以通过将上述各组分按顺序混合,搅拌均匀,灌装得到。本发明的中药液体敷料成分简单,成膜所需时间短,具有防水作用,抗菌效果好,无耐药性,能够促进伤口愈合,缩短伤口愈合时间。
The invention belongs to the field of medical dressings, and in particular relates to a traditional Chinese medicine liquid dressing and a preparation method, which contains the following components in weight percentage: 1.0%-6.0% of film-forming material, 2.0%-4.0% of glycerin, and 0.5%-3.0% of menthol , coptis extract 0.3%‑1.0%, honeysuckle extract 1.0%‑2.0%, and the rest is solvent. The traditional Chinese medicine liquid dressing of the present invention can be obtained by mixing the above components in sequence, stirring evenly and filling. The traditional Chinese medicine liquid dressing of the invention has simple ingredients, short film-forming time, waterproof effect, good antibacterial effect, no drug resistance, can promote wound healing, and shorten wound healing time.
Description
技术领域technical field
本发明属于医用敷料领域,具体涉及一种中药液体敷料及制备方法。The invention belongs to the field of medical dressings, in particular to a traditional Chinese medicine liquid dressing and a preparation method.
背景技术Background technique
医用敷料在伤口愈合过程中起到保护伤口、减少感染、吸收分泌物和促进伤口愈合的作用。传统纱布类敷料具有吸收性好、来源广泛、制备简单等优点,但也存在无法保持创面湿润、生物相容性差、易发生组织黏连、病原体易透过和伤口感染等问题。临床采用抗生素药物与纱布敷料结合预防伤口感染,但长期使用抗生素会产生耐药性。Medical dressings play a role in protecting the wound, reducing infection, absorbing secretions and promoting wound healing during the wound healing process. Traditional gauze dressings have the advantages of good absorption, wide range of sources, and simple preparation, but they also have problems such as inability to keep the wound moist, poor biocompatibility, easy tissue adhesion, easy penetration of pathogens, and wound infection. Antibiotics combined with gauze dressings are clinically used to prevent wound infection, but long-term use of antibiotics will lead to drug resistance.
随着医学治疗技术的发展,人们对医用敷料的要求提高,新型液体敷料应运而生。液体敷料在使用之前以液体形式储存,不受伤口位置和大小的限制,能够在伤口部位快速形成高分子薄膜。液体敷料具有良好的透气防水性,用后无需撕除,避免因更换敷料造成二次伤害。液体敷料由高分子成膜材料、溶剂以及功能性物质组成。高分子成膜材料包括天然高分子材料和合成高分子材料。天然高分子材料包括甲壳素、壳聚糖及衍生物、海藻酸钠等,这类高分子材料安全性高、生物相容性好。合成高分子材料包括聚乙烯醇、聚乙烯醇缩丁醛、卡波姆等。这类高分子材料具有特殊的化学结构,可以在酸或碱的作用下降解,同时其可为创面提供微湿、微酸和低氧环境,有利于伤口愈合。功能性物质包括助溶剂、助黏剂和抗菌消炎成分等。抗菌消炎成分包括纳米银、聚维酮碘和二氯苯氧氯酚等,但长期使用化学类抗菌剂会对健康造成伤害。With the development of medical treatment technology, people's requirements for medical dressings have increased, and new liquid dressings have emerged as the times require. Liquid dressings are stored in liquid form before use, and are not limited by the location and size of the wound, and can quickly form a polymer film at the wound site. The liquid dressing has good air permeability and water resistance, and there is no need to tear it off after use, avoiding secondary injuries caused by changing the dressing. Liquid dressings are composed of polymer film-forming materials, solvents and functional substances. Polymer film-forming materials include natural polymer materials and synthetic polymer materials. Natural polymer materials include chitin, chitosan and its derivatives, sodium alginate, etc. These polymer materials have high safety and good biocompatibility. Synthetic polymer materials include polyvinyl alcohol, polyvinyl butyral, carbomer, etc. This type of polymer material has a special chemical structure and can be degraded under the action of acid or alkali. At the same time, it can provide a slightly moist, slightly acidic and low-oxygen environment for the wound surface, which is conducive to wound healing. Functional substances include cosolvents, adhesion promoters, antibacterial and anti-inflammatory components, etc. Antibacterial and anti-inflammatory ingredients include nano-silver, povidone-iodine, and dichlorophenoxychlorophene, but long-term use of chemical antibacterial agents will cause harm to health.
中药由于其抗菌消炎、安全无毒和不易产生耐药性等优势在皮肤创口治疗中独具特色。然而,中药发挥疗效所需要的剂量较大,将中药粉末敷于伤口处,再用纱布包扎,存在保存与使用不便、药粉易脱落等问题,致使其在临床应用方面受到限制。Traditional Chinese medicine is unique in the treatment of skin wounds due to its advantages of antibacterial and anti-inflammatory, safe and non-toxic, and not easy to produce drug resistance. However, traditional Chinese medicine requires a large dose to exert its curative effect. Applying traditional Chinese medicine powder to the wound and then bandaging it with gauze has problems such as inconvenient storage and use, and the powder is easy to fall off, which limits its clinical application.
本发明将中药与液体成膜基质结合制备一种中药液体敷料,使得液体敷料具备抗菌消炎性能,同时其能够为创面提供微湿环境,具有优良的透气防水性能,不会产生耐药性,能够有效促进伤口愈合。The present invention combines traditional Chinese medicine with liquid film-forming matrix to prepare a traditional Chinese medicine liquid dressing, so that the liquid dressing has antibacterial and anti-inflammatory properties, and at the same time, it can provide a slightly humid environment for the wound surface, has excellent air permeability and waterproof performance, does not produce drug resistance, and can Effectively promote wound healing.
发明内容Contents of the invention
本发明的目的在于结合液体敷料与中药的优势,提供一种含有黄连、金银花提取物的中药液体敷料及制备方法,本发明的液体敷料能够在伤口处快速成膜,具有良好的生物相容性、抗菌性、透湿透气性,同时其安全无毒,不易产生耐药性,有利于伤口愈合。The purpose of the present invention is to combine the advantages of liquid dressings and traditional Chinese medicines to provide a Chinese medicinal liquid dressing containing extracts of Coptis chinensis and honeysuckle and a preparation method. The liquid dressing of the present invention can quickly form a film on the wound and has good biocompatibility , antibacterial, moisture permeability, and at the same time it is safe and non-toxic, not easy to produce drug resistance, and conducive to wound healing.
本发明的目的通过以下技术方案实现:一种中药液体敷料,其特征在于,包括以下重量百分比的原料:The object of the present invention is achieved through the following technical scheme: a kind of Chinese medicine liquid dressing, is characterized in that, comprises the raw material of following percentage by weight:
所述成膜材料是聚乙烯醇或者聚乙烯醇缩丁醛。The film-forming material is polyvinyl alcohol or polyvinyl butyral.
所述溶剂为蒸馏水或者乙醇。The solvent is distilled water or ethanol.
优选的液体敷料,包括以下重量百分比的原料:A preferred liquid dressing comprises the following raw materials in percentage by weight:
再优选的液体敷料,包括以下重量百分比的原料:A preferred liquid dressing comprises the following raw materials in percentage by weight:
所述聚乙烯醇的醇解度为87.0-89.0mol%,粘度为20.5-24.5mpa.s。The degree of alcoholysis of the polyvinyl alcohol is 87.0-89.0 mol%, and the viscosity is 20.5-24.5mpa.s.
所述聚乙烯醇缩丁醛的粘度为15.0-35.0mpa.s,丁醛基含量为45.0%-49.0%。The polyvinyl butyral has a viscosity of 15.0-35.0mpa.s and a butyraldehyde group content of 45.0%-49.0%.
所述一种中药液体敷料,其特征在于,所述中药提取物的制备可包括以下步骤:Described a kind of Chinese medicine liquid dressing is characterized in that, the preparation of described Chinese medicine extract can comprise the following steps:
1)将黄连粉碎,取其粉末加入到体积分数为60%的乙醇溶液中浸润过夜,之后加热回流提取3次,趁热过滤,合并3次滤液,将滤液浓缩后冷冻干燥,得到黄连提取物;1) Grind Coptidis rhizome, add its powder into ethanol solution with a volume fraction of 60% to infiltrate overnight, heat and reflux for extraction 3 times, filter while hot, combine the filtrates for 3 times, concentrate the filtrate and freeze-dry to obtain Coptis chinensis extract ;
2)将金银花粉碎,取其粉末加入到体积分数为60%的乙醇溶液中浸润过夜,之后加热回流提取2次,趁热过滤,合并滤液,将滤液浓缩后冷冻干燥,得到金银花提取物。2) The honeysuckle was pulverized, and its powder was added to an ethanol solution with a volume fraction of 60% to infiltrate overnight, then heated and refluxed for extraction twice, filtered while hot, combined with filtrates, concentrated and freeze-dried to obtain a honeysuckle extract.
所述一种中药液体敷料的制备方法,其特征在于,包括以下步骤:The preparation method of said a kind of traditional Chinese medicine liquid dressing, is characterized in that, comprises the following steps:
1)将成膜材料加热溶解,搅拌降温;1) heating and dissolving the film-forming material, stirring to cool down;
2)称取薄荷醇,加入到无水乙醇溶液中进行溶解;2) take menthol, join in absolute ethanol solution and dissolve;
3)称取黄连提取物,加入到体积分数为60%-70%的乙醇溶液中进行溶解;3) Weighing the Coptidis Rhizoma extract, adding it to an ethanol solution with a volume fraction of 60%-70% for dissolving;
4)称取金银花提取物,加入到体积分数为60%-70%的乙醇溶液中进行溶解;4) Weighing the honeysuckle extract, adding it to an ethanol solution with a volume fraction of 60%-70% for dissolving;
5)将甘油、薄荷醇溶液、黄连提取物溶液、金银花提取物溶液,按比例依次加入到过程1)中的成膜材料溶液中,充分搅拌至混合均匀;5) Add glycerin, menthol solution, Coptidis Rhizoma extract solution, and Flos Lonicerae extract solution in proportion to the film-forming material solution in process 1) in sequence, and stir until they are evenly mixed;
6)灌装,即得。6) Fill it and get it.
采用以上方案,本发明提供了一种中药液体敷料。其中,黄连和金银花作为抗菌物质。黄连提取物具有广谱抗菌作用,对大肠埃希氏菌、金黄色葡萄球菌、铜绿假单胞菌、痢疾志贺氏菌等具有显著的抑制作用。黄连提取物还具有免疫调节作用和抗肿瘤作用。金银花药用历史悠久,有“中药中的抗生素”之称。金银花提取物对急性、肉芽肿性以及慢性炎症均有一定的抑制作用,具有较强的广谱抗菌作用,同时还具有抗氧化和抗肿瘤活性。黄连与金银花配合使用,具有抗菌消炎功效,并且能够拓宽抗菌谱,不易产生耐药性。Adopting the above scheme, the invention provides a kind of traditional Chinese medicine liquid dressing. Among them, coptis and honeysuckle as antibacterial substances. Coptidis extract has broad-spectrum antibacterial effect, and has significant inhibitory effect on Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Shigella dysenteriae, etc. Coptidis extract also has immunomodulatory and antitumor effects. Honeysuckle has a long history of medicinal use, and it is known as "antibiotics in traditional Chinese medicine". Honeysuckle extract has certain inhibitory effect on acute, granulomatous and chronic inflammation, has strong broad-spectrum antibacterial effect, and also has antioxidant and anti-tumor activities. Coptis chinensis and honeysuckle are used in combination, which has antibacterial and anti-inflammatory effects, and can broaden the antibacterial spectrum, making it less likely to produce drug resistance.
本发明所使用的成膜材料均为生物相容性良好的高分子医用材料。其中,聚乙烯醇(PVA)是一种水溶性高分子材料,成膜性、柔软性和吸湿性均良好,是应用最广泛的成膜材料。聚乙烯醇缩丁醛(PVB)可溶解于醇类、酯类、酮类等多种有机溶剂,成膜所需时间少,成膜性和稳定性优良。The film-forming materials used in the present invention are high-molecular medical materials with good biocompatibility. Among them, polyvinyl alcohol (PVA) is a water-soluble polymer material with good film-forming properties, softness and hygroscopicity, and is the most widely used film-forming material. Polyvinyl butyral (PVB) can be dissolved in various organic solvents such as alcohols, esters, and ketones. It takes less time to form a film and has excellent film-forming properties and stability.
本发明将中药提取物加入到成膜材料中制备液体敷料;甘油作为保湿剂,增强抗菌膜的保湿作用,使抗菌膜柔软,紧贴患处。薄荷醇作为透皮促进剂,同时其作用于皮肤,具有清凉止痒作用,产生舒适感。In the invention, the extract of traditional Chinese medicine is added to the film-forming material to prepare a liquid dressing; glycerin is used as a humectant to enhance the moisturizing effect of the antibacterial film, making the antibacterial film soft and close to the affected part. Menthol acts as a transdermal accelerator, and at the same time it acts on the skin, has a cooling and antipruritic effect, and produces a sense of comfort.
本发明的中药液体敷料涂抹或者喷雾后成膜,具有良好的生物相容性,能够有效抵御细菌感染,保持创面湿润,不会因更换敷料对伤口造成二次伤害,从而促进伤口愈合,适用于小面积皮肤割伤、碰伤、擦伤和烧烫伤等。The traditional Chinese medicine liquid dressing of the present invention forms a film after smearing or spraying, has good biocompatibility, can effectively resist bacterial infection, keep the wound surface moist, and will not cause secondary damage to the wound due to changing the dressing, thereby promoting wound healing. Small area skin cuts, bruises, abrasions and burns etc.
综上所述,本发明的中药液体敷料具有以下优点:1)抗菌消炎效果好,缩短伤口愈合时间,2)便于观察伤口愈合情况,3)不易产生耐药性,4)防水性好,5)能够快速成膜,6)安全无毒,生物相容性好,7)工艺简单,适于规模化生产。In summary, the liquid dressing of traditional Chinese medicine of the present invention has the following advantages: 1) good antibacterial and anti-inflammatory effect, shortens wound healing time, 2) facilitates observation of wound healing, 3) is difficult to produce drug resistance, 4) good water resistance, 5) ) can quickly form a film, 6) is safe and non-toxic, has good biocompatibility, and 7) has a simple process and is suitable for large-scale production.
附图说明:Description of drawings:
图1(A)为本发明实施例1中的中药液体敷料的透射电镜图;(B)为本发明实施例4中的中药液体敷料的透射电镜图。Fig. 1 (A) is the transmission electron micrograph of the Chinese medicine liquid dressing in Example 1 of the present invention; (B) is the transmission electron microscope picture of the Chinese medicine liquid dressing in Example 4 of the present invention.
图2(A)为本发明实施例1中的中药液体敷料对金黄色葡萄球菌的抑菌圈测试结果图;(B)为本发明实施例1中的中药液体敷料对大肠埃希氏菌的抑菌圈测试结果图。Fig. 2 (A) is the bacteriostatic zone test result figure of the Chinese medicine liquid dressing in the embodiment of the present invention 1 to Staphylococcus aureus; (B) is the effect of the Chinese medicine liquid dressing in the embodiment of the present invention 1 to Escherichia coli The results of the zone of inhibition test.
图3为大鼠烫伤伤口愈合外观图(第3、7、15、21天),其中,A为实施例4中的中药液体敷料组;B为阳性对照组(红霉素组);C为阴性对照组(生理盐水组)。Fig. 3 is rat scald wound healing appearance figure (the 3rd, 7, 15, 21 days), wherein, A is the Chinese medicine liquid dressing group in embodiment 4; B is positive control group (erythromycin group); C is Negative control group (normal saline group).
图4为烫伤大鼠病理检测结果图,其中,A为烫伤大鼠;B为本发明实施例4中的中药液体敷料组;C为阳性对照组(红霉素组);D为阴性对照组(生理盐水组)。Fig. 4 is the scalded rat pathological detection result figure, and wherein, A is the scalded rat; B is the Chinese medicine liquid dressing group in the embodiment of the present invention 4; C is the positive control group (erythromycin group); D is the negative control group (normal saline group).
具体实施方式:detailed description:
下面结合实施例对本发明进行进一步说明。The present invention is further described below in conjunction with embodiment.
黄连提取物的制备:将黄连粉碎,取其粉末加入到12倍量体积分数为60%的乙醇溶液中浸润过夜,之后加热回流1h,趁热过滤,滤渣加入10倍量体积分数为60%的乙醇溶液加热回流1h,趁热过滤,滤渣加入8倍量体积分数为60%的乙醇溶液加热回流提取1h,再次趁热过滤,合并3次滤液,将滤液浓缩后冷冻干燥,得到黄连提取物,其中盐酸小檗碱含量为27.5%,巴马汀含量为7.3%,黄连碱的含量为6.2%,表小檗碱含量为4.2%;Preparation of Coptidis Rhizoma Extract: Grind Coptidis Rhizoma, add its powder to 12 times the volume fraction of 60% ethanol solution for soaking overnight, then heat to reflux for 1 hour, filter while it is hot, add 10 times the volume fraction of 60% ethanol solution to the filter residue Heat the ethanol solution under reflux for 1 hour, filter while it is hot, add 8 times the amount of ethanol solution with a volume fraction of 60% to the filter residue, heat and reflux it for extraction for 1 hour, filter it again while it is hot, combine the filtrates for 3 times, concentrate the filtrates and then freeze-dry to obtain the extract of Coptidis Rhizome. Wherein the berberine hydrochloride content is 27.5%, the palmatine content is 7.3%, the coptisine content is 6.2%, and the epiberberine content is 4.2%;
金银花提取物的制备:将金银花粉碎,取其粉末加入到10倍量体积分数为60%的乙醇溶液中浸润过夜,之后加热回流2h,趁热过滤,滤渣加入8倍量体积分数为60%的乙醇加热回流2h,再次趁热过滤,合并滤液,将滤液浓缩后冷冻干燥,得到金银花提取物,其中绿原酸含量为6.5%。Preparation of honeysuckle extract: Grind honeysuckle, take its powder and add 10 times the volume fraction of 60% ethanol solution to soak overnight, then heat and reflux for 2 hours, filter while it is hot, add 8 times the volume fraction of 60% ethanol solution to the filter residue The ethanol was heated to reflux for 2 hours, filtered again while it was hot, and the filtrates were combined, concentrated and then freeze-dried to obtain a honeysuckle extract, wherein the content of chlorogenic acid was 6.5%.
实施例1Example 1
一种中药液体敷料,包括以下重量百分比的原料,以100g为例:A kind of traditional Chinese medicine liquid dressing, comprises the raw material of following percentage by weight, takes 100g as example:
制备方法如下:The preparation method is as follows:
1)称取2.0g聚乙烯醇,加入到30mL蒸馏水中,于60℃进行机械搅拌至完全溶解,形成溶液A;1) Weigh 2.0g of polyvinyl alcohol, add it into 30mL of distilled water, and mechanically stir at 60°C until completely dissolved to form solution A;
2)称取0.7g薄荷醇,加入到6mL无水乙醇溶液中,搅拌至完全溶解,形成溶液B;2) Weigh 0.7g of menthol, add it into 6mL of absolute ethanol solution, stir until completely dissolved, and form solution B;
3)称取0.3g黄连提取物,加入到23mL体积分数为60%的乙醇溶液中,搅拌至完全溶解,形成溶液C;3) Weigh 0.3g of Coptis chinensis extract, add it into 23mL ethanol solution with a volume fraction of 60%, stir until completely dissolved, and form solution C;
4)称取1.0g金银花提取物,加入到45mL体积分数为60%的乙醇溶液中,搅拌至完全溶解,形成溶液D;4) Weigh 1.0 g of honeysuckle extract, add it to 45 mL of ethanol solution with a volume fraction of 60%, and stir until completely dissolved to form solution D;
5)将1.6mL甘油、溶液B、C、D依次加入到溶液A中,充分搅拌均匀;5) Add 1.6mL glycerin, solutions B, C, and D to solution A in turn, and stir well;
6)灌装。6) Filling.
实施例2Example 2
一种中药液体敷料,包括以下重量百分比的原料,以100g为例:A kind of traditional Chinese medicine liquid dressing, comprises the raw material of following percentage by weight, takes 100g as example:
制备方法如下:The preparation method is as follows:
1)称取4.0g聚乙烯醇,加入到27mL蒸馏水中,于60℃进行机械搅拌至完全溶解,形成溶液A;1) Weigh 4.0g of polyvinyl alcohol, add it into 27mL of distilled water, and mechanically stir at 60°C until completely dissolved to form solution A;
2)称取1.1g薄荷醇,加入到6mL无水乙醇溶液中,搅拌至完全溶解,形成溶液B;2) Weigh 1.1g of menthol, add it into 6mL of absolute ethanol solution, stir until completely dissolved, and form solution B;
3)称取0.5g黄连提取物,加入到23mL体积分数为60%的乙醇溶液中,搅拌至完全溶解,形成溶液C;3) Weigh 0.5 g of Coptidis rhizome extract, add it into 23 mL of ethanol solution with a volume fraction of 60%, stir until completely dissolved, and form solution C;
4)称取1.0g金银花提取物,加入到45mL体积分数为60%的乙醇溶液中,搅拌至完全溶解,形成溶液D;4) Weigh 1.0 g of honeysuckle extract, add it to 45 mL of ethanol solution with a volume fraction of 60%, and stir until completely dissolved to form solution D;
5)将1.8mL甘油、溶液B、C、D依次加入到溶液A中,充分搅拌均匀;5) Add 1.8mL glycerin, solutions B, C, and D to solution A in turn, and stir well;
6)灌装。6) Filling.
实施例3Example 3
一种中药液体敷料,包括以下重量百分比的原料,以100g为例:A kind of traditional Chinese medicine liquid dressing, comprises the raw material of following percentage by weight, takes 100g as example:
制备方法如下:The preparation method is as follows:
1)称取5.0g聚乙烯醇,加入到26mL蒸馏水中,于60℃进行机械搅拌至完全溶解,形成溶液A;1) Weigh 5.0g of polyvinyl alcohol, add it into 26mL of distilled water, and mechanically stir at 60°C until completely dissolved to form solution A;
2)称取1.5g薄荷醇,加入到4mL无水乙醇溶液中,搅拌至完全溶解,形成溶液B;2) Weigh 1.5g of menthol, add it into 4mL of absolute ethanol solution, stir until completely dissolved, and form solution B;
3)称取0.8g黄连提取物,加入到23mL体积分数为60%的乙醇溶液中,搅拌至完全溶解,形成溶液C;3) Weigh 0.8g of Coptis chinensis extract, add it into 23mL ethanol solution with a volume fraction of 60%, stir until completely dissolved, and form solution C;
4)称取1.6g金银花提取物,加入到45mL体积分数为60%的乙醇溶液中,搅拌至完全溶解,形成溶液D;4) Weigh 1.6g of honeysuckle extract, add it to 45mL ethanol solution with a volume fraction of 60%, and stir until completely dissolved to form solution D;
5)将2.0mL甘油、溶液B、C、D依次加入到溶液A中,充分搅拌均匀;5) Add 2.0mL glycerin, solutions B, C, and D to solution A in turn, and stir well;
6)灌装。6) Filling.
实施例4Example 4
一种中药液体敷料,包括以下重量百分比的原料,以100g为例:A kind of traditional Chinese medicine liquid dressing, comprises the raw material of following percentage by weight, takes 100g as example:
制备方法如下:The preparation method is as follows:
1)称取2.2g聚乙烯醇缩丁醛,加入到45mL无水乙醇溶液中,于50℃进行机械搅拌至完全溶解,形成溶液A;1) Weigh 2.2g of polyvinyl butyral, add it to 45mL of absolute ethanol solution, and mechanically stir at 50°C until completely dissolved to form solution A;
2)称取1.4g薄荷醇,加入到5mL无水乙醇溶液中,搅拌至完全溶解,形成溶液B;2) Weigh 1.4g of menthol, add it into 5mL of absolute ethanol solution, stir until completely dissolved, and form solution B;
3)称取0.3g黄连提取物,加入到27mL体积分数为70%的乙醇溶液中,搅拌至完全溶解,形成溶液C;3) Weigh 0.3g of Coptis chinensis extract, add it into 27mL ethanol solution with a volume fraction of 70%, and stir until completely dissolved to form solution C;
4)称取1.0g金银花提取物,加入到36mL体积分数为70%的乙醇溶液中,搅拌至完全溶解,形成溶液D;4) Weigh 1.0 g of honeysuckle extract, add it to 36 mL of ethanol solution with a volume fraction of 70%, and stir until completely dissolved to form solution D;
5)将1.6mL甘油、溶液B、C、D依次加入到溶液A中,充分搅拌均匀;5) Add 1.6mL glycerin, solutions B, C, and D to solution A in turn, and stir well;
6)灌装。6) Filling.
实施例5Example 5
一种中药液体敷料,包括以下重量百分比的原料,以100g为例:A kind of traditional Chinese medicine liquid dressing, comprises the raw material of following percentage by weight, takes 100g as example:
制备方法如下:The preparation method is as follows:
1)称取3.8g聚乙烯醇缩丁醛,加入到37mL无水乙醇溶液中,于50℃进行机械搅拌至完全溶解,形成溶液A;1) Weigh 3.8g of polyvinyl butyral, add it to 37mL of absolute ethanol solution, and mechanically stir at 50°C until completely dissolved to form solution A;
2)称取2.7g薄荷醇,加入到6mL无水乙醇溶液中,搅拌至完全溶解,形成溶液B;2) Weigh 2.7g of menthol, add it into 6mL of absolute ethanol solution, stir until completely dissolved, and form solution B;
3)称取0.6g黄连提取物,加入到27mL体积分数为70%的乙醇溶液中,搅拌至完全溶解,形成溶液C;3) Weigh 0.6g of Coptis chinensis extract, add it into 27mL ethanol solution with a volume fraction of 70%, stir until completely dissolved, and form solution C;
4)称取1.0g金银花提取物,加入到38mL体积分数为70%的乙醇溶液中,搅拌至完全溶解,形成溶液D;4) Weigh 1.0 g of honeysuckle extract, add it to 38 mL of ethanol solution with a volume fraction of 70%, and stir until completely dissolved to form solution D;
5)将2.0mL甘油、溶液B、C、D依次加入到溶液A中,充分搅拌均匀;5) Add 2.0mL glycerin, solutions B, C, and D to solution A in turn, and stir well;
6)灌装。6) Filling.
实施例6Example 6
一种中药液体敷料,包括以下重量百分比的原料,以100g为例:A kind of traditional Chinese medicine liquid dressing, comprises the raw material of following percentage by weight, takes 100g as example:
制备方法如下:The preparation method is as follows:
1)称取6.0g聚乙烯醇缩丁醛,加入到33mL无水乙醇溶液中,于50℃进行机械搅拌至完全溶解,形成溶液A;1) Weigh 6.0g of polyvinyl butyral, add it to 33mL of absolute ethanol solution, and mechanically stir at 50°C until completely dissolved to form solution A;
2)称取3.0g薄荷醇,加入到3mL无水乙醇溶液中,搅拌至完全溶解,形成溶液B;2) Weigh 3.0g of menthol, add it into 3mL of absolute ethanol solution, stir until completely dissolved, and form solution B;
3)称取1.0g黄连提取物,加入到34mL体积分数为70%的乙醇溶液中,搅拌至完全溶解,形成溶液C;3) Weigh 1.0 g of Coptis chinensis extract, add it to 34 mL of ethanol solution with a volume fraction of 70%, stir until completely dissolved, and form solution C;
4)称取1.5g金银花提取物,加入到32mL体积分数为70%的乙醇溶液中,搅拌至完全溶解,形成溶液D;4) Weigh 1.5g of honeysuckle extract, add it to 32mL ethanol solution with a volume fraction of 70%, and stir until completely dissolved to form solution D;
5)将3.0mL甘油、溶液B、C、D依次加入到溶液A中,充分搅拌均匀;5) Add 3.0mL glycerin, solutions B, C, and D to solution A in turn, and stir well;
6)灌装。6) Filling.
实施例7本发明的中药液体敷料的透射电镜测试The transmission electron microscope test of embodiment 7 Chinese medicine liquid dressing of the present invention
取实施例1、4制备的中药液体敷料,用移液枪取少量滴在直径为3mm的碳涂层铜网上,用滤纸吸去多余水分后,置于红外灯下干燥1h。将铜网送入透射电子显微镜,在200kv电压轰击下成像观察,以此表征该敷料的内部结构。结果见图1。Take the traditional Chinese medicine liquid dressing prepared in Examples 1 and 4, use a pipette gun to take a small amount and drop it on a carbon-coated copper grid with a diameter of 3 mm, absorb excess water with filter paper, and dry it under an infrared lamp for 1 hour. The copper mesh was sent to a transmission electron microscope, and imaged and observed under 200kv voltage bombardment, so as to characterize the internal structure of the dressing. The results are shown in Figure 1.
实施例8本发明的中药液体敷料的水蒸汽透过率The water vapor transmission rate of embodiment 8 Chinese medicine liquid dressing of the present invention
量取15mL实施例1-6制得的中药液体敷料,分别将其流延平铺于7cm×11.5cm透明玻璃板上,置于50℃烘箱内干燥30min,取出,从玻璃板上揭下药膜;称取0.5g药膜,将其覆盖在开口小瓶的瓶口处(面积为1.77cm2),其中小瓶中含有10g无水CaCl2,用聚四氟乙烯带将瓶口四周密封;阳性对照组采用密封的小瓶,小瓶中含有10g无水CaCl2;阴性对照组采用开口的小瓶,小瓶中含有10g无水CaCl2;将所有小瓶置于干燥器内,其中干燥器内含有饱和NaCl溶液(其相对湿度为70%RH),将干燥器置于37℃烘箱内,在一定的时间间隔测定小瓶的质量,计算水蒸汽透过率,结果见表1。Measure 15mL of the traditional Chinese medicine liquid dressing prepared in Examples 1-6, respectively spread it on a 7cm×11.5cm transparent glass plate, place it in a 50°C oven to dry for 30min, take it out, and peel off the drug film from the glass plate; Take by weighing 0.5g of the drug film, and cover it on the mouth of an open vial (with an area of 1.77cm 2 ), wherein the vial contains 10g of anhydrous CaCl 2 , and seal around the mouth of the bottle with a polytetrafluoroethylene tape; the positive control group Adopt sealed vial, contain 10g anhydrous CaCl in the vial ; Negative control group adopts the vial of opening, contain 10g anhydrous CaCl in the vial ; All vials are placed in desiccator, wherein contain saturated NaCl solution (its The relative humidity is 70% RH), the desiccator is placed in a 37°C oven, the quality of the vial is measured at a certain time interval, and the water vapor transmission rate is calculated. The results are shown in Table 1.
表1中药液体敷料水蒸汽透过率实验结果Table 1 Experimental results of water vapor transmission rate of traditional Chinese medicine liquid dressing
从表1可知,实验组与阴性对照组相比,可以有效地减少水蒸汽透过率,因此本发明的中药液体敷料所形成的药膜可以防止水分散失,维持创面湿润。As can be seen from Table 1, compared with the negative control group, the experimental group can effectively reduce the water vapor transmission rate, so the drug film formed by the traditional Chinese medicine liquid dressing of the present invention can prevent water loss and keep the wound moist.
实施例9本发明的中药液体敷料的成膜时间The film-forming time of embodiment 9 Chinese medicine liquid dressings of the present invention
量取1.5mL实施例1、4制得的中药液体敷料,分别将其流延平铺于2.5cm×7.5cm透明玻璃板上,秒表开始计时,膜体从玻璃板上揭起时,计时停止,结果见表2.Measure 1.5mL of the traditional Chinese medicine liquid dressing prepared in Examples 1 and 4, spread it on a 2.5cm×7.5cm transparent glass plate, and start timing with a stopwatch. When the membrane body is lifted from the glass plate, the timing stops. The results are shown in Table 2.
表2中药液体敷料成膜时间测试结果Table 2 Test results of film-forming time of Chinese herbal liquid dressing
从表2可知,本发明的中药液体敷料的成膜时间随着温度增高而缩短,在37℃的成膜时间可缩短至2min。As can be seen from Table 2, the film-forming time of the traditional Chinese medicine liquid dressing of the present invention shortens as the temperature increases, and the film-forming time at 37° C. can be shortened to 2 minutes.
实施例10本发明的中药液体敷料的抑菌效果The antibacterial effect of embodiment 10 Chinese medicine liquid dressing of the present invention
中药提取物体外抗菌活性测定:采用琼脂稀释法,测定中药提取物的最低抑菌浓度(MIC)。实验菌株采用金黄色葡萄球菌(Staphylococcus aureus ATCC29213)、粪肠球菌(Enterococcus faecalis ATCC 29212)、大肠埃希氏菌(Escherichia coli ATCC25922)、肺炎克雷伯菌(Klebsiella pneumonia ATCC700603)和铜绿假单胞菌(Pseudomonasaeruginosa CMCC(B)10104)等。结果显示,黄连提取物MIC值为2.5mg/mL,金银花提取物MIC值为10mg/mL。Determination of antibacterial activity of traditional Chinese medicine extracts in vitro: the minimum inhibitory concentration (MIC) of traditional Chinese medicine extracts was determined by agar dilution method. The experimental strains were Staphylococcus aureus ATCC29213, Enterococcus faecalis ATCC 29212, Escherichia coli ATCC25922, Klebsiella pneumonia ATCC700603 and Pseudomonas aeruginosa (Pseudomonasaeruginosa CMCC (B) 10104) and so on. The results showed that the MIC value of Coptidis Rhizoma extract was 2.5mg/mL, and the MIC value of Honeysuckle extract was 10mg/mL.
中药液体敷料的抑菌效果的测定:Determination of antibacterial effect of traditional Chinese medicine liquid dressing:
样品制备:称取50mg黄连提取物,加入到10mL体积分数为60%的乙醇溶液中,得到黄连提取物药液;称取100mg金银花提取物,加入到10mL体积分数为60%的乙醇溶液中,得到金银花提取物药液。取实施例1-6制备的中药液体敷料。Sample preparation: Weigh 50 mg of Coptis chinensis extract, add it to 10 mL of ethanol solution with a volume fraction of 60%, to obtain a solution of Coptis chinensis extract; weigh 100 mg of honeysuckle extract, add it to 10 mL of ethanol solution with a volume fraction of 60%, Obtain honeysuckle extract liquid. Get the Chinese medicinal liquid dressing prepared in Examples 1-6.
菌种选择:以金黄色葡萄球菌(Staphylococcus aureus ATCC29213)代表革兰氏阳性菌,大肠埃希氏菌(Escherichia coli ATCC25922)代表革兰氏阴性菌,购买于江苏省康华医药科技实业中心。Bacteria selection: Staphylococcus aureus (Staphylococcus aureus ATCC29213) represents Gram-positive bacteria, Escherichia coli (Escherichia coli ATCC25922) represents Gram-negative bacteria, purchased from Kanghua Medical Technology Industrial Center, Jiangsu Province.
培养基:细菌培养基为pH值为7.2±0.2的营养琼脂培养基。培养基购买于北京三药科技开发公司。Culture medium: the bacterial culture medium is a nutrient agar medium with a pH value of 7.2±0.2. The medium was purchased from Beijing Sanyao Science and Technology Development Company.
测定方法:用平板打孔法测定实施例1-6制备的中药液体敷料的抑菌圈大小,评判本发明的中药液体敷料的抑菌活性。将2mL稀释的菌悬液(108cfu/mL)加入到50℃水浴条件下体积为200mL的液态培养基中,并混合均匀。将20mL上述混有菌悬液的培养基转移到培养皿中使其凝固(菌落数为106-107cfu/mL)。用打孔器在平板上打出3个孔,分布均匀,距边为1.5cm,用灭菌牙签将琼脂块挑出,火焰封底。每个孔注入70μL液体敷料,于37℃进行培养24h。抑菌圈测定结果见图2。抑菌圈直径见表3。Measuring method: measure the antibacterial zone size of the traditional Chinese medicine liquid dressing prepared in Examples 1-6 with the plate punching method, and evaluate the antibacterial activity of the traditional Chinese medicine liquid dressing of the present invention. Add 2 mL of the diluted bacterial suspension (10 8 cfu/mL) into a liquid medium with a volume of 200 mL in a water bath at 50°C, and mix well. Transfer 20 mL of the above culture medium mixed with the bacterial suspension to a petri dish to solidify (the number of colonies is 10 6 -10 7 cfu/mL). Punch 3 holes on the plate with a puncher, evenly distributed, 1.5cm away from the side, pick out the agar block with a sterilized toothpick, and seal the bottom with flame. 70 μL of liquid dressing was injected into each well, and incubated at 37° C. for 24 hours. The results of the inhibition zone test are shown in Figure 2. The diameter of the inhibition zone is shown in Table 3.
表3中药液体敷料的抑菌圈直径Table 3 The diameter of the antibacterial zone of traditional Chinese medicine liquid dressing
从表3可知,黄连提取物对金黄色葡萄球菌与大肠埃希氏菌均有较好的抑制作用,金银花提取物对金黄色葡萄球菌的抑制效果优于对大肠埃希氏菌的抑制效果;本发明的中药液体敷料与中药提取物相比,增强了抑菌效果,且随着中药提取物含量的增高,其抑菌效果也增强。As can be seen from Table 3, Coptis chinensis extract has better inhibitory effect on Staphylococcus aureus and Escherichia coli, and the inhibitory effect of honeysuckle extract on Staphylococcus aureus is better than that on Escherichia coli; Compared with the traditional Chinese medicine extract, the traditional Chinese medicine liquid dressing of the present invention has enhanced antibacterial effect, and with the increase of the content of the traditional Chinese medicinal extract, the antibacterial effect is also enhanced.
实施例11本发明的中药液体敷料的安全性评价The safety evaluation of embodiment 11 Chinese medicine liquid dressing of the present invention
取体重为200-220g雄性SD大鼠(购自浙江省实验动物中心),采用8%硫化钠溶液作为脱毛剂,对大鼠背部进行脱毛处理,并用温水洗去脱下的毛和脱毛剂。将实施例1-6制备的中药液体敷料涂抹于脱毛部位,每只大鼠500μL,每天涂抹1次,连续涂抹一周并观察,评价其安全性。结果显示,和未涂抹大鼠皮肤相比,本发明的中药液体敷料对皮肤并无任何不良反应。Take a male SD rat with a body weight of 200-220g (purchased from Zhejiang Experimental Animal Center), use 8% sodium sulfide solution as a depilatory, depilate the back of the rat, and wash off the hair and depilatory with warm water. The traditional Chinese medicine liquid dressing prepared in Examples 1-6 was applied to the depilatory site, 500 μL per rat, once a day, continuously applied for one week and observed, and its safety was evaluated. The results show that, compared with the rat skin without smearing, the traditional Chinese medicine liquid dressing of the present invention does not have any adverse reaction to the skin.
实施例12本发明的中药液体敷料对大鼠烫伤伤口的愈合作用Embodiment 12 Chinese medicine liquid dressing of the present invention is to the healing effect of scalded wound of rat
烫伤大鼠模型:实验采用体重为200-220g雄性SD大鼠(购自浙江省实验动物中心),适应性饲养一周后,按其体重随机分为:阳性对照组(红霉素组)、阴性对照组(生理盐水组)和实验组(实施例1-6制备的中药液体敷料),每组6只。将大鼠麻醉,用8%硫化钠溶液对大鼠背部进行脱毛处理,并用温水洗去脱下的毛和脱毛剂。24h后,用乙醚将大鼠麻醉,将其待烫伤部位用75%酒精溶液消毒。烫伤采用50g砝码(直径为2cm),将砝码置于100℃沸水中平衡1min,快速擦干水分后,置于脱毛部位15s,立刻移除砝码,分别将实施例1-6制备的中药液体敷料500μL、生理盐水500μL、红霉素0.5g涂布在伤口处,每只大鼠单笼饲养。每天对大鼠伤口更换一次敷料,于伤后第3、5、7、11、15、21天测定伤口面积来记录伤口面积的变化并计算伤口愈合率。伤口愈合率计算:用半透明硫酸纸描绘出伤口,剪下伤口部分的纸片,置于天平上称重并换算成面积。伤口愈合率=(原始伤口面积-未愈合伤口面积)/原始伤口面积×100%。大鼠烫伤伤口愈合外观见图3。病理检测结果见图4。伤口愈合率结果见表4。Scald rat model: The experiment uses male SD rats with a body weight of 200-220g (purchased from Zhejiang Experimental Animal Center). After one week of adaptive feeding, they are randomly divided into positive control group (erythromycin group), negative The control group (physiological saline group) and the experimental group (traditional Chinese medicine liquid dressing prepared in Examples 1-6), 6 rats in each group. The rat was anesthetized, and the back of the rat was depilated with 8% sodium sulfide solution, and the depilated hair and depilatory were washed with warm water. After 24 hours, the rats were anesthetized with ether, and the parts to be scalded were disinfected with 75% alcohol solution. Use a 50g weight (2cm in diameter) for scalding, place the weight in boiling water at 100°C for 1 min, dry the water quickly, place it on the depilated area for 15 seconds, remove the weight immediately, and place the weights prepared in Examples 1-6 respectively 500 μL of traditional Chinese medicine liquid dressing, 500 μL of normal saline, and 0.5 g of erythromycin were applied to the wound, and each rat was reared in a single cage. The dressings were changed once a day on the wounds of the rats, and the wound area was measured on the 3rd, 5th, 7th, 11th, 15th, and 21st days after injury to record the change of the wound area and calculate the wound healing rate. Calculation of wound healing rate: draw the wound with translucent sulfuric acid paper, cut off the wound part of the paper, put it on a balance and weigh it and convert it into an area. Wound healing rate=(original wound area-unhealed wound area)/original wound area×100%. The appearance of rat scald wound healing is shown in Figure 3. The pathological detection results are shown in Figure 4. The results of the wound healing rate are shown in Table 4.
表4各个实验组大鼠伤口愈合率(n=6)Each experimental group rat wound healing rate of table 4 ( n=6)
从表4可知,本发明的中药液体敷料对大鼠烫伤伤口的愈合效果与阳性对照组接近,其差异无统计学意义(P>0.05);在第21天时,大鼠创面基本愈合;在相同的时间内,实验组的愈合率明显高于阴性对照组(P<0.01)。伤口愈合率结果与病理检测结果一致。从图4可知,在伤口愈合后期,实验组与阳性对照组的皮肤角质已经形成,皮下组织的毛囊、毛囊腺基本正常;而阴性对照组上皮重度脱落,皮下组织的毛囊腺体出现大面积的坏死,纤维组织重度增生。本发明的中药液体敷料与红霉素均能改善大鼠的病理损伤,对大鼠烫伤伤口具有显著的促进愈合作用。As can be seen from Table 4, the healing effect of the traditional Chinese medicine liquid dressing of the present invention on rat scald wounds is close to that of the positive control group, and the difference has no statistical significance (P>0.05); on the 21st day, the wounds of the rats were healed substantially; The healing rate of the experimental group was significantly higher than that of the negative control group (P<0.01). The results of wound healing rate were consistent with the results of pathological examination. It can be seen from Figure 4 that in the later stage of wound healing, the skin keratin of the experimental group and the positive control group has been formed, and the hair follicles and hair follicle glands of the subcutaneous tissue are basically normal; while the epithelium of the negative control group is severely shed, and the hair follicle glands of the subcutaneous tissue appear large areas Necrosis, severe hyperplasia of fibrous tissue. Both the traditional Chinese medicine liquid dressing and the erythromycin of the invention can improve the pathological damage of rats, and can significantly promote healing of scalded wounds of rats.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610949158.2A CN106310362A (en) | 2016-10-28 | 2016-10-28 | Traditional Chinese medicine liquid dressing and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610949158.2A CN106310362A (en) | 2016-10-28 | 2016-10-28 | Traditional Chinese medicine liquid dressing and preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106310362A true CN106310362A (en) | 2017-01-11 |
Family
ID=57819485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610949158.2A Pending CN106310362A (en) | 2016-10-28 | 2016-10-28 | Traditional Chinese medicine liquid dressing and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106310362A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107308490A (en) * | 2017-06-07 | 2017-11-03 | 常州市天宁区鑫发织造有限公司 | A kind of preparation method of liquid antibiotic wound-protecting film |
CN110201218A (en) * | 2018-12-23 | 2019-09-06 | 山东泰开制药有限公司 | Liquid adhesive bandage and preparation method thereof |
CN110882413A (en) * | 2019-12-11 | 2020-03-17 | 河南承东生物科技有限公司 | Water-soluble long-acting physical antibacterial liquid dressing and preparation method thereof |
CN111991604A (en) * | 2020-08-30 | 2020-11-27 | 云南古润生物科技有限责任公司 | Adhesive bandage based on cannabidiol and manufacturing method thereof |
CN113952498A (en) * | 2021-09-28 | 2022-01-21 | 江西中医药大学 | Chinese medicine multi-component liquid wound healing dressing and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103083713A (en) * | 2012-12-10 | 2013-05-08 | 江苏华亿细胞组织工程有限公司 | Sterile polymerized covering dressing for wound surface |
CN105457080A (en) * | 2015-12-09 | 2016-04-06 | 安徽宇宁生物科技有限公司 | Pectin adhesive bandage |
-
2016
- 2016-10-28 CN CN201610949158.2A patent/CN106310362A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103083713A (en) * | 2012-12-10 | 2013-05-08 | 江苏华亿细胞组织工程有限公司 | Sterile polymerized covering dressing for wound surface |
CN105457080A (en) * | 2015-12-09 | 2016-04-06 | 安徽宇宁生物科技有限公司 | Pectin adhesive bandage |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107308490A (en) * | 2017-06-07 | 2017-11-03 | 常州市天宁区鑫发织造有限公司 | A kind of preparation method of liquid antibiotic wound-protecting film |
CN110201218A (en) * | 2018-12-23 | 2019-09-06 | 山东泰开制药有限公司 | Liquid adhesive bandage and preparation method thereof |
CN110882413A (en) * | 2019-12-11 | 2020-03-17 | 河南承东生物科技有限公司 | Water-soluble long-acting physical antibacterial liquid dressing and preparation method thereof |
CN111991604A (en) * | 2020-08-30 | 2020-11-27 | 云南古润生物科技有限责任公司 | Adhesive bandage based on cannabidiol and manufacturing method thereof |
CN113952498A (en) * | 2021-09-28 | 2022-01-21 | 江西中医药大学 | Chinese medicine multi-component liquid wound healing dressing and preparation method thereof |
CN113952498B (en) * | 2021-09-28 | 2022-11-29 | 江西中医药大学 | A kind of traditional Chinese medicine multi-component liquid healing wound dressing and its preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110354295B (en) | Photo-thermal conversion material and preparation method thereof | |
CN109045349A (en) | A kind of hydrogel skin wound dressing and preparation method thereof that antibacterial heal-promoting closes | |
CN101879283B (en) | Novel membrane spraying preparation for skin trauma and preparation method | |
CN106310350A (en) | Hydrogel woundplast containing traditional Chinese medicine extracts and preparation method thereof | |
CN106310362A (en) | Traditional Chinese medicine liquid dressing and preparation method | |
CN107185031B (en) | A kind of biologically active medical dressing and preparation method thereof | |
CN105012993A (en) | Medical and antibacterial cationic biogel dressing and preparation method thereof | |
CN106975095B (en) | A kind of antibacterial medical auxiliary material and preparation method thereof | |
CN103272153A (en) | Antibacterial gel and preparation method thereof | |
CN103385926A (en) | Antibiosis gel for curing cervical and vaginal diseases of gynaecology | |
CN105363064A (en) | Compound aloe vera polysaccharide gel antiseptic dressing for treating burns | |
CN105250696A (en) | Traditional Chinese medicine gel capable of promoting skin wound to heal and preparation method of traditional Chinese medicine gel | |
CN103893640B (en) | A kind of chitosan infant bio-medical antimicrobial fluid and preparation method thereof | |
CN105169455B (en) | A kind of burn and scald external application first aid medical dressing and preparation method thereof | |
CN104491838B (en) | Anti-HPV (human papillomavirus) gel dressing and preparation method thereof | |
CN105477341A (en) | Liquid adhesive bandage and preparation method thereof | |
CN107753347B (en) | A kind of hydrogel acid pomegranate powder skin care product and preparation method and application thereof | |
CN111012945B (en) | A kind of waterproof traditional Chinese medicine liquid band-aid and preparation method thereof | |
CN105411746A (en) | Nanometer multilayer composite hemostasis plaster, and preparing method and application thereof | |
CN105250333B (en) | A kind of pharmaceutical composition of antibacterial skin moistening and preparation method thereof | |
CN105233271B (en) | A kind of anti-scar salamander collagen burn cream and preparation method thereof | |
CN114931662B (en) | Skin care dressing and preparation method thereof | |
CN109224124B (en) | Liquid dressing for stopping bleeding and promoting healing | |
CN112023110A (en) | Active antibacterial dressing based on bamboo fungus egg extract | |
CN104873479A (en) | Collagen polypeptide skin membrane capable of reducing swelling and relieving itching and preparation method of collagen polypeptide skin membrane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170111 |
|
WD01 | Invention patent application deemed withdrawn after publication |